Inflammation, Fibrosis and Neovascularisation: New Perspectives for Old Foes in the Pathogenesis of Neovascular AMD
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".
Deadline for manuscript submissions: closed (30 January 2024) | Viewed by 2677
Special Issue Editors
Interests: macular degeneration; photoreceptors; retina; immune system; ophthalmology; bionic eye; glia
Interests: eyes in ageing and disease
Special Issue Information
Dear Colleagues,
Choroidal neovascularisation manifests in advanced macular degeneration as a pathological growth of blood vessels in the choroid. The new blood vessel growth resulting from the choroid is leaky and, if untreated, leads to severe vision loss. Choroidal neovascularisation is akin to a maladaptive wound-healing response. The remodeled choroidal tissue environment is fibrotic and pro-inflammatory. Treatments that target neovascular-promoting factors (e.g., vascular endothelial growth factor and angiopoietin) have revolutionised our ability to prevent vision loss in neovascular macular degeneration. However, vision loss can continue to occur as treatments are unable to treat the subretinal fibrosis and inflammation that accompanies choroidal neovascularisation. Improving our understanding of the molecular processes that underpin these responses is, therefore, crucial to help ameliorate vision loss in neovascular macular degeneration.
For this Special Issue, we would like to invite papers that investigate and discuss the molecular signaling that drives choroidal neovascularisation pathogenesis and/or diagnosis or treatments. Suggested areas are molecular mechanisms of neovascularisation, fibrosis, and inflammation that regulate choroidal neovascularisation in preclinical or clinical settings. This includes novel treatment approaches that target or incorporate gene and cell therapies for choroidal neovascularization and identification or proposal of potential biomarkers (e.g., imaging, blood, or eye fluid) that are either implicated or associated with choroidal neovascularisation. Clinical research that includes molecular mechanism studies will also be welcomed.
Dr. Alice Brandli
Dr. Matt Rutar
Dr. Helder Andre
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- macular degeneration
- age-related macular degeneration
- angiogenesis
- choroidal neovascularisation
- fibrosis
- wound healing
- retinal pigment epithelium
- choroid
- optical coherance tomography
- biomarkers
- inflammation
- complement
- endothelial growth factor
- growth factor
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
